World Forum

In May the World Medical Innovation Forum featured panel discussions and content on cell and gene therapies across the sector. More than 20 hours of programming featured 150+ experts including clinical/scientific leaders, industry CEOs, venture investors, entrepreneurs, government decision makers and media. Topics covered Videos of all Forum sessions are now available, including: Fireside Chats…

For each 2021 World Medical Innovation panel over the course of three days, visual drawings were made to encapsulate what was discussed in an illustrative way. To view, download them all here.

Day 3 of the World Medical Innovation Forum codified the challenges of bringing new gene and cell therapies to market—shared across treatment strategies, delivery systems and disease areas. Priority needs included more reliable and repeatable manufacturing processes, building resiliency into the supply chain, and working with regulators to develop more streamlined pathways to approval. Venture…

Day Two of the World Medical Innovation Forum took a deeper dive into the potential of GCT therapeutics to treat different diseases—from ultra-rare genetic disorders to highly prevalent chronic diseases such as diabetes. Discussions touched on different strategies for modifying genes and delivering therapies, as well as opportunities for using lessons learned from last year’s…

“Now that the first crop of gene and cell therapy (GCT) treatments have reached the market, where should the field head next?” “How can patients, clinicians, regulators, payers and members of industry work collaboratively to expand the reach of these treatments—and pave the way for future success?” Those were questions tackled on Day 1 of…

At the 2020 World Medical Innovation Forum, Joerg Moeller, MD, PhD reflected on how Bayer is weathering the organizational challenges posed by the COVID-19 pandemic. Moderated by Janet Wu of Bloomberg, this fireside chat covered possible treatments for COVID-19, the challenges of drug development while labs are shut down, and the lessons that the industry…

The long-term impacts of COVID-19 on healthcare, society and the economy are only beginning to reveal themselves. More than a thousand experts provide their thoughts on what’s ahead. We’re pleased to share the following analysis. Download Now

Deployed in the crucible of the coronavirus pandemic, digital health has now become an essential pillar in the delivery of care. Alistair Erskine, MD of Mass General Brigham, Adam Landman, MD of Brigham Health, Brooke LeVasseur of AristaMD, and Lee Schwamm, MD of Massachusetts General Hospital discuss how the outbreak of COVID-19 accelerated the use…

At the 2020 World Medical Innovation Forum, experts leading large teams at the epicenter of the coronavirus outbreak discussed how technology is shaping the pandemic response today and in the coming years. In this panel, Stéfane Bancel of Moderna, Paul Biddinger, MD of Massachusetts General Hospital, David Kaufman of the Bill & Melinda Gates Medical…

Medical Imaging, Mental Health, Suicide Prevention Make the List of Coming Applications Partners HealthCare today announced its selections for the fifth annual “Disruptive Dozen,” the 12 emerging artificial intelligence (AI) technologies with the greatest potential to impact health care in the next year. The technologies were featured as part of the World Medical Innovation Forum…

The MGH & BWH Center for Clinical Data Science wants to put AI in the toolbox of every researcher and clinician Boston, MA April 08, 2019 – At the World Medical Innovation Forum 2019, Partners HealthCare today announced a commitment to put artificial intelligence (AI) in the toolbox of all of its researchers and clinicians.…

Partners HealthCare in Massachusetts is one of the nation’s epicenters of healthcare research, quality care delivery, and innovative health IT design. From MGH and Harvard Medical School to Brigham and Women’s and the Spaulding Rehabilitation Network, the vast resources at the command of researchers and clinicians make the health system the perfect place to experiment…

The annual World Medical Innovation Forum (WMIF) is coming to Boston, April 8-10, covering artificial intelligence (AI) in clinical care. Don’t miss Harvard faculty, 60 CEOs and top corporate leaders discussing the innovations driving future investment, research, and patient care. Network with other leaders from start-up tech, AI companies, academic medicine, venture finance, and industry…

Register Today. April 8–10, 2019  |  Boston www.worldmedicalinnovation.org